NEVVI Medicare utilization intelligence
or

← back

Provider profile

CHINEKE, ILOABUEKE MD

Hematology-Oncology · NPI 1740700798 · CASPER, WY

1
Groups
67
Codes · 2024
133,896
Disclosed services

CHINEKE, ILOABUEKE is a Hematology-Oncology in CASPER, WY, a member of 1 medical group, who billed 67 distinct codes to Medicare Part B in 2024.

Groups: ROCKY MOUNTAIN ONCOLOGY CENTER LLC (CASPER, WY)

Year: 2024 · 2023

Provider overview · all codes · CY2024

133,896
disclosed services
67
codes billed to Medicare Part B
Prior year · CY2023 51,654 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0897 Injection, denosumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J0640 Injection, leucovorin calcium, per 50 mg
Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3480 Injection, potassium chloride, per 2 meq
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9045 Injection, carboplatin, 50 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
96375 Injection of additional new drug or substance into vein
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
84443 Blood test, thyroid stimulating hormone (tsh)
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3475 Injection, magnesium sulfate, per 500 mg
77014 Ct guidance for insertion of radiation therapy fields
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3490 Unclassified drugs
82378 Carcinoembryonic antigen (cea) protein level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
83615 Lactate dehydrogenase (enzyme) level
82728 Ferritin (blood protein) level
84153 Psa (prostate specific antigen) measurement, total
77336 Continuing radiation therapy consultation per week
71260 Ct scan of chest with contrast
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
74177 Ct scan of abdomen and pelvis with contrast
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96361 Infusion into a vein for hydration, each additional hour
83735 Magnesium level
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
83550 Iron binding capacity
96360 Infusion into a vein for hydration, 31-60 minutes
84550 Uric acid level, blood
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
83540 Iron level
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
80048 Blood test, basic group of blood chemicals (calcium, total)
70491 Ct scan of soft tissue of neck with contrast
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.